Dr. Candy Kaihing Chan, MD, PhD

Dr. Chan practices at Turning Point Physical Therapy - Temple City in Temple City, California.

Dr. Chan's NPI, 1497876254, was assigned on April 2, 2007. Dr. Chan graduated from Keck School of Medicine of USC in 2005. Dr. Chan holds California license A98768.

Dr. Chan's primary practice is Turning Point Physical Therapy - Temple City, at 9627 Las Tunas Dr, Temple City, CA 91780. The practice phone is (626) 292-1793.

Dr. Chan's primary practice is Turning Point Physical Therapy - Temple City in Temple City, California. Dr. Chan is also affiliated with Huntington Hospital. Dmand AI also links Dr. Chan to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chan practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Chan's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Chan is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Chan's licenses on file in 7 states: California, Oregon, Maine, Washington, Iowa, Louisiana and New York.

Dmand AI lists age-related macular degeneration, cataract, cold sores or genital herpes, conjunctivitis, glaucoma, hypertensive retinopathy, retinal detachment and retinal occlusion among the conditions Dr. Chan treats.

CMS data shows 1,509 Medicare services from Dr. Chan across 10 procedure codes in 2024, for 196 Medicare patients. Medicare paid $202,183 for them.

CMS counts 196 Medicare patients who saw Dr. Chan in 2024. The largest group is 65 to 74, with 87 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chan's median patient age at 65, with 57% women.

In 2024, Dr. Chan wrote 87 Medicare Part D claims for 27 patients. 74% of them were for generic drugs. CMS names the drug for 44 of them, across 3 drugs with 11 or more claims each, at $3,199 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

Dr. Chan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Chan, published from 2006 to 2014. The most frequent topics are Angiogenesis Inhibitors, Neovascularization, Pathologic and Retinal Vessels. Dr. Chan has published most often in Am J Ophthalmol. Dr. Chan's most frequent co-authors are Jay Kumar Chhablani, MD, William R. Freeman, MD and Cynthia Chinn, MD.

CMS Open Payments shows 25 general payments to Dr. Chan from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $511.

Dr. Chan graduated from Keck School of Medicine of USC in 2005.

Dr. Chan is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.